ANB-004
/ Biocad
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2023
Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL)
(clinicaltrials.gov)
- P1/2 | N=40 | Recruiting | Sponsor: Biocad
New P1/2 trial • Viral vector • Genetic Disorders • Movement Disorders • Muscular Atrophy • Rare Diseases
1 to 1
Of
1
Go to page
1